KHN senior Colorado correspondent Markian Hawryluk discussed how a rural Colorado town is crowdsourcing ways to get prescription medicines delivered on KUNC’s “Colorado Edition” on Monday. KHN Editor-in-Chief Elisabeth Rosenthal discussed how medical education changed during the pandemic on NPR’s “Here and Now” on Tuesday. KHN freelancer Amy Worden chatted about high vaccine hesitancy among… Read More »
Lyme disease affects an estimated 300,000 people in the United States each year. Despite its increasing prevalence, there are many lingering myths about this tick-borne illness. Also known as the “great imitator,” Lyme disease often affects more than one system in the body and can trigger a wide range of symptoms that may mimic other… Read More »
Essential Reads: Neurosteroids, Allopregnanolone and Vulnerability to Depression in Women Women are twice as likely as men to suffer from a depressive disorder. In addition, they are vulnerable to mood disorders associated with reproductive functioning, specifically premenstrual dysphoric disorder, perinatal depression, and perimenopausal depression. There is strong evidence to indicate that biological factors (genetic vulnerability,… Read More »
Healthcanal.comhttps://www.healthcanal.com Healthcare and Wellness Informative SourceFri, 16 Jul 2021 06:10:14 +0000en-US hourly 1 https://wordpress.org/?v=5.7.2https://www.healthcanal.com/wp-content/uploads/2021/01/logo-02-1.pngHealthcanal.comhttps://www.healthcanal.com 323210 Quick & Effective Exercises To Lose Butt Fat Permanentlyhttps://www.healthcanal.com/life-style-fitness/exercises-to-lose-butt-fat Fri, 16 Jul 2021 09:03:37 +0000https://www.healthcanal.com/?post_type=informational_posts&p=267351 Want to lose butt fat permanently? Exercises To Lose Butt Fat? You are not alone. Getting a toned butt is a fitness goal for many… Read More »
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes WHIPPANY, N.J.– July 9, 2021 (BUSINESS WIRE)– Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained… Read More »